I 
109TH CONGRESS 
1ST SESSION 
H. R. 184
To amend the Controlled Substances Import and Export Act to provide 
authority to the Attorney General to authorize any controlled substance 
that is in schedule I or II or is a narcotic drug in schedule III or 
IV to be exported from the United States to a country for subsequent 
export from that country to another country, if certain conditions are 
met. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 4, 2005
Mr. PITTS (for himself, Ms. ESHOO, Mr. CANNON, Mr. BISHOP of Utah, and 
Mr. CUNNINGHAM) introduced the following bill; which was referred to 
the Committee on Energy and Commerce, and in addition to the Com-
mittee on the Judiciary, for a period to be subsequently determined by 
the Speaker, in each case for consideration of such provisions as fall with-
in the jurisdiction of the committee concerned 
A BILL 
To amend the Controlled Substances Import and Export 
Act to provide authority to the Attorney General to au-
thorize any controlled substance that is in schedule I 
or II or is a narcotic drug in schedule III or IV to 
be exported from the United States to a country for 
subsequent export from that country to another country, 
if certain conditions are met.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Controlled Substances 
Export Reform Act of 2005’’. 
SEC. 2. SUBSEQUENT EXPORT OF CONTROLLED SUB-
STANCES. 
Section 1003 of the Controlled Substances Import 
and Export Act (21 U.S.C. 953) is amended by adding 
at the end the following subsection: 
‘‘(f) Notwithstanding subsections (a)(4) and (c)(3), 
the Attorney General may authorize any controlled sub-
stance that is in schedule I or II or is a narcotic drug 
in schedule III or IV to be exported from the United 
States to a country for subsequent export from that coun-
try to another country, if each of the following conditions 
is met: 
‘‘(1) Both the country to which the controlled 
substance is exported from the United States (re-
ferred to in this subsection as the ‘first country’) 
and the country to which the controlled substance is 
exported from the first country (referred to in this 
subsection as the ‘second country’) are parties to the 
Single Convention on Narcotic Drugs, 1961, and the 
Convention on Psychotropic Substances, 1971. 
‘‘(2) The first country and the second country 
have each instituted and maintain, in conformity 
with such Conventions, a system of controls of im-
ports of controlled substances which the Attorney 
General deems adequate. 
‘‘(3) With respect to the first country, the con-
trolled substance is consigned to a holder of such 
permits or licenses as may be required under the 
laws of such country, and a permit or license to im-
port the controlled substance has been issued by the 
country. 
‘‘(4) With respect to the second country, sub-
stantial evidence is furnished to the Attorney Gen-
eral by the person who will export the controlled 
substance from the United States that—
‘‘(A) the controlled substance is to be con-
signed to a holder of such permits or licenses 
as may be required under the laws of such 
country, and a permit or license to import the 
controlled substance is to be issued by the coun-
try; and 
‘‘(B) the controlled substance is to be ap-
plied exclusively to medical, scientific, or other 
legitimate uses within the country. 
‘‘(5) The controlled substance will not be ex-
ported from the second country. 
‘‘(6) Within 30 days after the controlled sub-
stance is exported from the first country to the sec-
ond country, the person who exported the controlled 
substance from the United States delivers to the At-
torney General documentation certifying that such 
export from the first country has occurred. 
‘‘(7) A permit to export the controlled sub-
stance from the United States has been issued by 
the Attorney General.’’.
Æ